Forum Discussion
Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
I agree with all you ladies. I feel guilty going on the palas trial. I'm in the group receiving palbociclib for early breast cancer. My oncologist keeps saying it should be on the pbs soon. I hope for all the sakes of you ladies with mets that it's available in the near future.